Intravenous magnesium sulphate does not improve survival or disability outcomes in people with stroke - 24/08/11
Abstract |
Question |
Does intravenous magnesium sulphate improve survival or disability outcomes if given within 12 hours of stroke onset?
Study design |
Multicentre randomised controlled trial.
Main results |
Intravenous magnesium sulphate did not significantly improve survival or disability outcomes at 90 days compared with placebo in people with stroke (see Table 1).
|
Authors’ conclusions |
Intravenous magnesium sulphate given within 12 hours of stroke does not improve survival or disability outcomes.
Le texte complet de cet article est disponible en PDF.Keywords : Stroke, Magnesium, Survival, Randomised controlled trial
Plan
Abstracted from: Lees KR, Muir KW, Ford I et al. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet 2004; 363: 439–445. |
Vol 8 - N° 4
P. 227-229 - août 2004 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?